---
title: "Advancing Cell & Gene Therapies: Tools and Techniques for Improving Outcomes"
description: Optimize cell and gene therapy yields with automated media exchange, GMP single-use reactors, and acoustic cell separation in stirred tank bioreactors.
---

[![BPI Media\_Logo 2\_Color 1](https://bpi.bioprocessintl.com/hs-fs/hubfs/BPI%20Media_Logo%202_Color%201.png?width=350&height=161&name=BPI%20Media_Logo%202_Color%201.png)](https://bioprocessintl.com/)

#                                          ![BPI Media\_AsktheExpert\_590 x 197\_Header\_for\_Landing\_Pages](https://bpi.bioprocessintl.com/hs-fs/hubfs/BPI%20Media_AsktheExpert_590%20x%20197_Header_for_Landing_Pages.jpg?width=543&height=181&name=BPI%20Media_AsktheExpert_590%20x%20197_Header_for_Landing_Pages.jpg)

# Advancing Cell & Gene Therapies:

# Tools and Techniques for Improving Outcomes

|  |
| --- |

## ![Picture2-1](https://bpi.bioprocessintl.com/hs-fs/hubfs/Picture2-1.png?width=200&height=30&name=Picture2-1.png)

## Presenter:

****![10-06-2026-Getinge-ATE-Speaker-HS-Cropped-1](https://bpi.bioprocessintl.com/hs-fs/hubfs/10-06-2026-Getinge-ATE-Speaker-HS-Cropped-1.jpg?width=160&height=228&name=10-06-2026-Getinge-ATE-Speaker-HS-Cropped-1.jpg)****

**George Barringer**

*Senior Product Manager, North America,*

Getinge Life Sciences 

 

George Barringer is the senior product manager, North America for Getinge Life Sciences and is responsible for the Getinge Applikon Bioreactor product line. The line includes stirred tank bioreactors in scales from 250mL to 5000L in muti-use glass, single use, and stainless steel SIP construction for product development to commercial applications, bioreactor controllers, sensors, and all bioreactor accessories. He has over 25 years of experience supporting biopharma, industrial biotech, academic applications, and clients from the laboratory bench to commercial scale with expertise in product design, development, applications, manufacturing, sales, and marketing.

 

 

 

## About this event:

#### Date: October 6, 2026

#### Time: 11 am EDT | 8 am PDT | 5 pm CEST

#### Duration: 30 minutes

| This webcast will focus on cell and gene therapy culture in stirred tank reactors, describing and detailing three techniques and products which promise to enhance and optimize product yield and quality in any scale of operation. George Barringer, senior product manager from Getinge, will discuss automated media exchange, which will improve efficiency and accuracy of this vital function in stem cell culture. GMP single-use reactors with integrated feed and harvest tubing manifolds (Box to Bench™) will be described for use in scale-up or scale-out scenarios, from product development laboratories to clinical production. The last section will describe Getinge's proprietary acoustic cell separation perfusion device (BioSep™) and its use in and technique for separating and retaining highly shear-sensitive cells in the stirred tank bioreactor environment, improving product quality and yield. Key Takeaways: - Automated media exchange improves efficiency and accuracy in stem cell culture workflows. - The role of GMP single-use reactors with integrated manifolds in seamless scale-up and scale-out from development to clinical production. - Acoustic cell separation technology enhances product quality and yield by protecting shear-sensitive cells during perfusion culture. |
| --- |

 

-  

-  

©2015 BioProcess International All Rights reserved